Integrative radiation carcinogenesis: Interactions between cell and tissue responses to DNA damage

Seminars in Cancer Biology

Volumn 15, Issue 2, 2005, Pages 138-148

  Barcellos Hoff, Mary Helen ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Carcinogenesis; DNA damage; Ionizing radiation; Stromal epithelial; TGF

Indexed keywords

PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA1;

BIOSENSOR; CANCER RADIOTHERAPY; CANCER RISK; CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELL INTERACTION; CELL TYPE; DNA DAMAGE; GENE TARGETING; HUMAN; IONIZING RADIATION; MICROENVIRONMENT; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

NON-PROGRAMMATIC;

ANIMALS; CELL COMMUNICATION; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; HUMANS; NEOPLASMS; RADIATION, IONIZING; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12344310463     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2004.08.010     Document Type: Review

References (102)

1. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 50 57
2. H. Rubin Cancer as a dynamic developmental disorder Cancer Res. 45 1985 2935 2942
3. M.H. Barcellos-Hoff The potential influence of radiation-induced microenvironments in neoplastic progression J. Mammary Gland Biol. Neoplasia 3 1998 165 175
4. C. Sonnenschein, and A.M. Soto Somatic mutation theory of carcinogenesis: why it should be dropped and replaced Mol. Carcinogen. 29 2000 205 211
5. M.J. Bissell, and D. Radisky Putting tumours in context Nat. Rev.: Cancer 1 2001 1 11
6. B.S. Wiseman, and Z. Werb Stromal effects on mammary gland development and breast cancer Science 296 2002 1046 1049
7. Pierce GB, Shikes R, Fink LM. Cancer: a problem of developmental biology; 1978.
8. M.H. Barcellos-Hoff It takes a tissue to make a tumor: epigenetics, cancer and the microenvironment J. Mammary Gland Biol. Neoplasia 6 2001 213 221
9. C. Kuperwasser, T. Chavarria, M. Wu, G. Magrane, J.W. Gray, and L. Carey From the cover: reconstruction of functionally normal and malignant human breast tissues in mice PNAS 101 2004 4966 4971
10. N.A. Bhowmick, A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, and S. Shappell Tgf-{beta} signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 2004 848 851
11. M.V. Maffini, A.M. Soto, J.M. Calabro, A.A. Ucci, and C. Sonnenschein The stroma as a crucial target in rat mammary gland carcinogenesis J. Cell Sci. 117 2004 1495 1502
12. M. Tokunaga, C.E. Land, and S. Tokuoka Follow-up studies of breast cancer incidence among atomic bomb survivors J. Radiat. Res. (Tokyo) 32 Suppl. 1991 201 211
13. A. Mattsson, B-I. Ruden, N. Wilking, and L.E. Rutqvist Radiation-induced breast cancer: Long-term follow-up of radiation therapy for benign breast disease J. Natl. Cancer Inst. 85 1993 1679 1685
14. P. Mauch Second malignancies after curative radiation therapy for good prognosis cancers Int. J. Radiat. Oncol. Biol. Phys. 33 1995 959 960
15. F.G. Davis, J.D. Boice, Z. Hrubec, and R.R. Monson Cancer mortality in a radiation-exposed cohort of massachusetts tuberculosis patients Can. Res. 49 1989 6130 6136
16. L. Huang, A.R. Snyder, and W.F. Morgan Radiation-induced genomic instability and its implications for radiation carcinogenesis Oncogene 22 2003 5848 5854
17. M.H. Barcellos-Hoff How do tissues respond to damage at the cellular level? The role of cytokines in irradiated tissues Radiat. Res. 150 1998 S109 S120
18. M.H. Barcellos-Hoff, and A.L. Brooks Extracellular signaling via the microenvironment: a hypothesis relating carcinogenesis, bystander effects and genomic instability Radiat. Res. 156 2001 618 627
19. J.E. Trosko Hierarchcal and cybernetic nature of biologic systems and their relevance to homeostatic adaptation to low-level exposures to oxidative stress-inducing agents Environ. Health Perspect. 106 1998 331 339
20. R.D. Cardiff, M.R. Anver, B.A. Gusterson, L. Hennighausen, R.A. Jensen, and M.J. Merino The mammary pathology of genetically engineered mice: the consensus report and recommendations from the annapolis meeting Oncogene 19 2000 968 988
21. M.J. Bissell, D. Radisky, A. Rizki, V.M. Weaver, and O.W. Petersen The organizing principle: microenvironmental influences in the normal and malignant breast Differentiation 70 2002 537 546
22. M.H. Barcellos-Hoff Radiation-induced transforming growth factor β and subsequent extracellular matrix reorganization in murine mammary gland Cancer Res. 53 1993 3880 3886
23. M.H. Barcellos-Hoff, R. Derynck, M.L.-S. Tsang, and J.A. Weatherbee Transforming growth factor-β activation in irradiated murine mammary gland J. Clin. Invest. 93 1994 892 899
24. E.J. Ehrhart, A. Carroll, P. Segarini, M.L.-S. Tsang, and M.H. Barcellos-Hoff Latent transforming growth factor-β activation in situ: quantitative and functional evidence following low dose irradiation FASEB J. 11 1997 991 1002
25. J.M. Onoda, M.P. Piechocki, and K.V. Honn Radiation-induced increase in expression of αiibβ3 integrin in melanoma cells: effects on metastatic potential Radiat. Res. 130 1992 281 288
26. S.N. Mooteri, J.L. Podolski, E.A. Drab, T.J. Saclarides, J.M. Onoda, and S.S. Kantak Wr-1065 and radioprotection of vascular endothelial cells II. Morphology Radiat. Res. 145 1996 217 224
27. M. Delcommence, and C.H. Streuli Control of integrin expression by extracellular matrix J. Biol. Chem. 270 1995 26794 26801
28. R.O. Hynes Integrins: a family of cell surface receptors Cell 48 1987 549 554
29. V.M. Weaver, O.W. Petersen, F. Wang, C.A. Larabell, P. Briand, and C. Damsky Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies J. Cell Biol. 137 1997 231 245
30. M.M. Zutter, G. Mazoujian, and S.A. Santoro Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast Am. J. Pathol. 137 1990 863 870
31. R. Bhatia, P.B. McGlave, and C.M. Verfaillie Treatment of marrow stroma with interferon-alpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors Role of mip-1 alpha J. Clin. Invest. 96 1995 931 939
32. T.D. Tlsty Cell-adhesion-dependent influences on genomic instability and carcinogenesis Curr. Opin. Cell Biol. 10 1998 647 653
33. C.J. Sympson, M.J. Bissell, and Z. Werb Mammary gland tumor formation in transgenic mice overexpressing stromelysin-1 Semin. Cancer Biol. 6 1995 159 163
34. C. Nathan, and M. Sporn Cytokines in context J. Cell Biol. 113 1991 981 986
35. D.A. Lawrence, R. Pircher, and P. Jullien Conversion of a high molecular weight latent beta-TGF from chicken embryo fibroblasts into a low molecular weight active beta-TGF under acidic conditions Biochem. Biophys. Res. Commun. 133 1985 1026 1034
36. M.H. Barcellos-Hoff, E.J. Ehrhart, M. Kalia, R. Jirtle, K. Flanders, and M.L.-S. Tsang Immunohistochemical detection of active TGF-β in situ using engineered tissue Am. J. Pathol. 147 1995 1228 1237
37. K.B. Ewan, R.L. Henshall-Powell, S.A. Ravani, M.J. Pajares, C. Arteaga, and R. Warters Transforming growth factor-{beta}1 mediates cellular response to DNA damage in situ Cancer Res. 62 2002 5627 5631
38. M.H. Barcellos-Hoff, and T.A. Dix Redox-mediated activation of latent transforming growth factor-β1 Mol. Endocrinol. 10 1996 1077 1083
39. M.H. Barcellos-Hoff Latency and activation in the regulation of TGF-β J. Mammary Gland Biol. Neoplasia 3 1996 353 363
40. E.J. Ehrhart, E.L. Gillette, and M.H. Barcellos-Hoff Immunohistochemical evidence of rapid extracellular matrix remodeling after iron-particle irradiation of mouse mammary gland Radiat. Res. 145 1996 157 162
41. S.V. Costes, C.H. Streuli, and M.H. Barcellos-Hoff Quantitative image analysis of laminin immunoreactivity in 1 gev/amu iron particle irradiated skin basement membrane Radiat. Res. 154 2000 389 397
42. J.I. Merryman, N. Neilsen, and D.D. Stanton Transforming growth factor-beta enhances the ultraviolet-mediated stress response in p53-/- keratinocytes Int. J. Oncol. 13 1998 781 789
43. M.B. Kastan, O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig Participation of p53 protein in the cellular response to DNA damage Cancer Res. 51 1991 6304 6311
44. D.E. Fisher Apoptosis in cancer therapy: crossing the threshold Cell 78 1994 539 542
45. M.L. Agarwal, A. Agarwal, W.R. Taylor, and G.R. Stark P53 controls both the g2/m and the g1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts Proc. Natl. Acad. Sci. U.S.A. 92 1995 8493 8497
46. Y. Landesman, F. Bringold, D.D. Milne, and D.W. Meek Modifications of p53 protein and accumulation of p21 and gadd45 mrna in TGF-beta 1 growth inhibited cells Cell. Signall. 9 1997 291 298
47. T. Teramoto, A. Kiss, and S.S. Thorgeirsson Induction of p53 and bax during TGF-beta 1 initiated apoptosis in rat liver epithelial cells Biochem. Biophys. Res. Commun. 251 1998 56 60
48. D.J. Jerry, C. Kuperwasser, S.R. Downing, J. Pinkas, C. He, and E. Dickinson Delayed involution of the mammary epithelium in balb/c-p53null mice Oncogene 17 1998 2305 2312
49. R. Strange, F. Li, S. Saurer, A. Burkhardt, and R.R. Friis Apoptotic cell death and tissue remodeling during mouse mammary gland involution Development (Camb.) 115 1992 49 58
50. B.I. Gerwin, E. Spillare, K. Forrester, T.A. Lehman, J. Kispert, and J.A. Welsh Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1 Proc. Natl. Acad. Sci. U.S.A. 89 1992 2759 2763
51. M. Reiss, V.F. Vellucci, and Z.L. Zhou Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes Cancer Res. 53 1993 899 904
52. F.S. Wyllie, T. Dawson, J.A. Bond, P. Goretzki, S. Game, and S. Prime Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation Mol. Cell. Endocrinol. 76 1991 13 21
53. A.M. Thompson, C.M. Steel, U. Chetty, J.M. Dixon, and D.C. Carter Transforming growth factor beta 1 is unlikely to mediate p53 abnormalities in breast cancer Br. J. Surg. 82 1995 210 211
54. A.C. Williams, S.J. Browne, A.M. Manning, P. Daffada, T.J. Collard, and C. Paraskeva Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the aa/c1 human adenoma derived cell line, including sensitivity to transforming growth factor-beta 1 Oncogene 9 1994 1479 1485
55. L. Brenner, T. Muñoz-Antonia, V.F. Vellucci, Z.L. Zhou, and M. Reiss Wild-type p53 tumor suppressor gene restores differentiation of human squamous carcinoma cells but not the response to transforming growth factor beta Cell Growth Differ. 4 1993 993 1004
56. M. Reiss, and M.H. Barcellos-Hoff Transforming growth factor-β in breast cancer: a working hypothesis Br. Cancer Res. Treat. 45 1997 81 95
57. F. Dkhissi, S. Raynal, P. Jullien, and D.A. Lawrence Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein Oncogene 18 1999 703 711
58. 2 and phorphorylation of 30 kilodalton proteins as early responses of cell cycle-dependent inhibition of DNA synthesis by transforming growth factor β1 Cell Growth Differ. 2 1991 583 591
59. S.K. Das, A.C. White, and B.L. Fanburg Modulation of transforming growth factor-β1 antiproliferative effects on endothelial cells by cysteine, cystine, and n-acetylcysteine J. Clin. Invest. 90 1992 1649 1656
60. M. Ohba, M. Shibanuma, T. Kuroki, and K. Nose Production of hydrogen peroxide by transforming growth factor-β1 and its involvement in induction of egr-1 in mouse osteoblastic cells J. Cell Biol. 126 1994 1079 1088
61. 2-generating nadh oxidase in human lung fibroblasts by transforming growth factor β1 J. Biol. Chem. 270 1995 30334 30338
62. C. Langer, J.M. Jurgensmeier, and G. Bauer Reactive oxygen species act at both TGF-beta-dependent and -independent steps during induction of apoptosis of transformed cells by normal cells Exp. Cell Res. 222 1996 117 124
63. A. Sanchez, A.M. Alvarez, M. Benito, and I. Fabrega Apoptosis induced by transforming growth factor-β in fetal hepatocyte primary cultures: involvement of reactive oxygen intermediates J. Biol. Chem. 271 1996 7416 7422
64. 2 release from bovine pulmonary artery endothelial cells induced by TGF-β1 Am. J. Physiol. 265 1993 L622 L626
65. P.K. Narayanan, E.H. Goodwin, and B.E. Lehnert Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells Cancer Res. 57 1997 3963 3971
66. B.E. Lehnert, and E.H. Goodwin Extracellular factor(s) following exposure to alpha particles can cause sister chromatid exchanges in normal human cells Cancer Res. 57 1997 2164 2171
67. A.B. Glick, W.C. Weinberg, I.H. Wu, W. Quan, and S.H. Yuspa Transforming growth factor beta 1 suppresses genomic instability independent of a g1 arrest, p53, and rb Cancer Res. 56 1996 3645 3650
68. T. Ohmori, J.L. Yang, J.O. Price, and C.L. Arteaga Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy Exp. Cell Res. 245 1998 350 359
69. B.A. Teicher, Y. Maehara, Y. Kakeji, G. Ara, S.R. Keyes, and J. Wong Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorin Int. J. Cancer 71 1997 49 58
70. M.D. Sternlicht, A. Lochter, C.J. Sympson, B. Huey, J.P. Rougier, and J.W. Gray The stromal proteinase mmp3/stromelysin-1 promotes mammary carcinogenesis Cell 98 1999 137 146
71. M.H. Barcellos-Hoff, and S.A. Ravani Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells Cancer Res. 60 2000 1254 1260
72. K.B. DeOme, L.J.J. Faulkin, H.A. Bern, and P.B. Blair Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female c3h mice Cancer Res. 19 1959 515 520
73. K.G. Danielson, C.J. Oborn, E.M. Durban, J.S. Buetel, and D. Medina Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro Proc. Natl. Acad. Sci. U.S.A. 81 1984 3756 3760
74. S.M. Campbell, M.M. Taha, D. Medina, and J.M. Rosen A clonal derivative of mammary epithelial cell line comma-d retains stem cell characteristics of unique morphological and functional heterogeneity Exp. Cell Res. 177 1988 109 121
75. D.J. Jerry, D. Medina, and J.S. Butel P53 mutations in comma-d cells In Vitro Cell. Dev. Biol. 30A 1994 87 89
76. A. Lochter, S. Galosy, J. Muschler, N. Freedman, Z. Werb, and M.J. Bissell Matrix metalloproteinase stomelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and premalignant phentoype in mammary epithelial cells J. Cell Biol. 139 1997 1861 1872
77. J. Greenberger, M. Epperly, A. Zeevi, K. Brunson, K. Goltry, and K. Pogue-Geile Stromal cell involvement in leukemogenesis and carcinogenesis In Vivo 10 1996 11 17
78. A.C. Erickson, and M.H. Barcellos-Hoff The not-so innocent bystander: microenvironment as a target of cancer therapy Expert Opin. Ther. Targets 7 2003 71 88
79. O.W. Petersen, L. Ronnov-Jessen, A.R. Howlett, and M.J. Bissell Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells Proc. Natl. Acad. Sci. U.S.A. 89 1992 9064 9068
80. M.H. Barcellos-Hoff, J. Aggeler, T.G. Ram, and M.J. Bissell Functional differentiation and alveolar morphogenesis of primary mammary epithelial cells cultures on reconstituted basement membrane Development 105 1989 223 235
81. C.C. Park, R. Henshall-Powell, A.C. Erickson, R. Talhouk, B. Parvin, and M.J. Bissell Ionizing radiation induces heritable disruption of epithelial cell-microenvironment interactions Proc. Natl. Acad. Sci. U.S.A. 100 2003 10728 10733
82. B.M. Gumbiner Regulation of cadherin adhesive activity J. Cell Biol. 148 2000 399 404
83. R. Heimann, F. Lan, R. McBride, and S. Hellman Separating favorable from unfavorable prognostic markers in breast cancer: the role of e-cadherin Cancer Res. 60 2000 298 304
84. K. Vleminckx, L.J. Vakaet, M. Mareel, W. Fiers, and F. van Roy Genetic manipulation of e-cadherin expression by epithelial tumor cells reveals an invasion suppressor role Cell 66 1991 107 119
85. C.B. Vos, A.M. Cleton-Jansen, G. Berx, W.J. de Leeuw, N.T. ter Haar, and F. van Roy E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis Br. J. Cancer 76 1997 1131 1133
86. S.K. Gupta, A.G. Douglas-Jones, B. Jasani, J.M. Morgan, M. Pignatelli, and R.E. Mansel E-cadherin (e-cad) expression in duct carcinoma in situ (dcis) of the breast Virchows Arch. 430 1997 23 28
87. M.M. Saunders, M.J. Seraj, Z. Li, Z. SZhou, C.R. Winter, and D.R. Welch Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication Cancer Res. 61 2001 1765 1767
88. M.M. Faraldo, M-A. Deugnier, M. Lukashev, J.P. Thiery, and M.A. Glukhova Perturbation of β1-integrin function alters the development of the murine mammary gland. EMBO J. 17 1998 2139 2147
89. T. Klinowska, J.V. Soriano, J. Oliver, A. Valentijn, R. Montesano, and C. Streuli Laminin and β1 integrins are crucial for normal mammary gland development in the mouse Dev. Biol. 215 1999 13 32
90. T.C. Klinowska, C.M. Alexander, E. Georges_Labouesse, R. Van_der_Neut, J.A. Kreidberg, and C.J. Jones Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits Dev. Biol. 233 2001 449 467
91. J. Luo, D.M. Lubaroff, and M.J. Hendrix Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by e-cadherin transfection Cancer Res. 59 1999 3552 3556
92. K. Kamiya, J. Yasukawa-Barnes, J.M. Mitchen, M.N. Gould, and K.H. Clifton Evidence that carcinogenesis involves an imbalance between epigenetic high-frequency initiation and suppression of promotion Proc. Natl. Acad. Sci. U.S.A. 92 1995 1332 1336
93. M.A. Kadhim, S.A. Lorimore, K.M. Townsend, D.T. Goodhead, V.J. Buckle, and E.G. Wright Radiation-induced genomic instability: delayed cytogenetic aberrations and apoptosis in primary human bone marrow cells Int. J. Radiat. Biol. 67 1995 287 293
94. M.A. Kadhim, D.A. Macdonald, D.T. Goodhead, S.A. Lorimore, S.J. Marsden, and E.G. Wright Transmission of chromosomal instability after plutonium alpha-particle irradiation [see comments] Nature 355 1992 738 740
95. C. Mothersill, M.A. Kadhim, S. O'Reilly, D. Papworth, S.J. Marsden, and C.B. Seymour Dose- and time-response relationships for lethal mutations and chromosomal instability induced by ionizing radiation in an immortalized human keratinocyte cell line Int. J. Radiat. Biol. 76 2000 799 806
96. J.L. Salisbury The contribution of epigenetic changes to abnormal centosomes and genomic instability in breast cancer J Mammary Gland Biol Neopl 6 2001 203 212
97. G.A. Pihan, A. Purohit, J. Wallace, R. Malhotra, L.A. Liotta, and S.J. Doxsey Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression Cancer Res. 61 2001 2212 2219
98. S. Duensing, A. Duensing, C.P. Crum, and K. Munger Human papillomavirus type 16 e7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype Cancer Res. 61 2001 2356 2360
99. L. von Bertalanffy General system theory: a new approach to unity of science 1. Problems of general system theory Hum. Biol. 23 1951 302 312
100. Orosz CG. In: Segal LA, Cohen IR, editors. An introduction to immuno-ecology and immuno-informatics. Design principles for immune system & other distriubted autonomous systems. 2001. p. 125-49.
101. H. Kitano Cancer as a robust system: Implications for anticancer therapy Nat. Rev. Cancer 4 2004 227 235
102. H. Rubin Microenvironmental regulation of the initiated cell Adv. Cancer Res. 90 2003 1 62